NCT04392531View on ClinicalTrials.gov

Clinical Trial to Assess Efficacy of cYclosporine Plus Standard of Care in Hospitalized Patients With COVID19

PHASE4CompletedINTERVENTIONAL
Enrollment

111

Participants

Timeline

Start Date

April 16, 2020

Primary Completion Date

March 31, 2021

Study Completion Date

March 31, 2021

Conditions
COVID19 Infection
Interventions
DRUG

Cyclosporine

In the experimental group, cyclosporine will be started according to patient weight, and then increased depending on patient tolerance (monitoring renal function and blood pressure)

DRUG

Standard treatment

Standard of care according to hospital protocol

Trial Locations (7)

28040

Fundacion Jimenez Diaz, Madrid

28342

Hospital Infanta Elena, Valdemoro

28400

Hospital General de Villalba, Villalba

28933

Hospital Rey Juan Carlos, Móstoles

Unknown

Complejo Hospitalario Universitario La Coruña, A Coruña

Hospital Quiron La Coruña, A Coruña

Clinica Universitaria de Navarra, Madrid

All Listed Sponsors
lead

Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz

OTHER

NCT04392531 - Clinical Trial to Assess Efficacy of cYclosporine Plus Standard of Care in Hospitalized Patients With COVID19 | Biotech Hunter | Biotech Hunter